NOV 13, 2015 1:29 PM PST

Scientists Created Killer Cells To Attack Cancer

WRITTEN BY: Kara Marker
Natural killer (NK) cells are lymphocytes normally found in the body that play a vital role in inducing cell death in abnormal cells like cancerous cells. Unfortunately, cancer often spreads too fast and too far for NK cells to prevent fatality. However, scientists from Cornell figured out a way to give these NK cells a boost, so cancer won't be able to stand a chance.

Referred to as "super natural killer cells," these specialized lymphocytes designed by Dr. Michael R. King and his team from Cornell are programmed to find and destroy cancer cells in the lymph nodes. Also known as stage II or III cancer, tumor cells "hang out" in lymph nodes in preparation for metastasis (stage IV cancer). Killing the cancer cells before they spread could greatly reduce the severity of disease surrounding continuous cancer development.
 
An NK cell attacking a cancer cell

The mechanism behind the super natural killer cells involves injecting liposomes armed with specialized receptors that attach to NK cells already in the lymph nodes. These specialized receptors, called "tumor necrosis factor related apoptosis-inducing ligand" (TRAIL), enhance the already-working, apoptosis-inducing, cancer-killing behavior of NK cells. Instead of letting the cancer slip away to metastasize, the cancer cell population is completely eliminated.

"We want to see lymph node metastasis become a thing of the past," said King. The paper resulting from his study was published in Biomaterials this month. 

With successful clinical trials completed in mice, this technology is one step closer to preventing cancer metastasis in humans. Diagnoses of cancer types like colorectal, breast, and lung cancers in the lymph nodes occur between 29 and 37 percent of the time. This technology could stop the cancer from moving any further than this and subsequently save a lot of lives.

Watch the following real time video of an NK cell destroying a cancerous cell.
 

 
Source: Cornell University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 04, 2019
Immunology
OCT 04, 2019
Researchers Identify Pair of "Recruiters" that Pull T Cells to the Lungs
How do CD8 T cells make it to the lungs to help in the fight against infection? Why don’t T cells remain longer in the lungs? How can science optimiz...
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
FEB 19, 2020
Immunology
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from the University of Pennsylvania’...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and over. Managing their condition with...
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: having an anti-inflammatory effect on lu...
Loading Comments...